Cargando…
Rituxan-Induced Tumor Lysis Syndrome in a Patient With Diffuse Large B-Cell Lymphoma
Rituximab or Rituxan is a common drug used in the treatment of lymphomas. It is almost always used in conjunction with other chemotherapy regimens. Mechanism of action involves killing of the CD 20+ cells. Rituximab is implicated in precipitating tumor lysis syndrome (TLS) in patients with diffused...
Autores principales: | Iftikhar, Saffa, Khokher, Waleed, Gekonde, Joan, Kesireddy, Nithin, Mudiyanselage, Prabath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418554/ https://www.ncbi.nlm.nih.gov/pubmed/34513493 http://dx.doi.org/10.7759/cureus.16921 |
Ejemplares similares
-
THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021) -
Spontaneous Tumor Lysis Syndrome in Diffuse Large B-cell Lymphoma: Early Diagnosis and Management
por: Gangireddy, Mounika, et al.
Publicado: (2019) -
Subacute Cutaneous Lupus as a Paraneoplastic Manifestation of Non-Hodgkin Lymphoma
por: Khokher, Waleed, et al.
Publicado: (2022) -
An HIV Associated Plasmablastic Lymphoma With Spontaneous Tumor Lysis Syndrome
por: Al Sbihi, Ali F, et al.
Publicado: (2020) -
Does a Starting Positive End-Expiratory Pressure of 8 cmH(2)O Decrease the Probability of a Ventilator-Associated Event?
por: Barnett, William R., et al.
Publicado: (2021)